Small trials and drug safety: when will we learn?
Markovitz
Barry P
BP
D001279:Atracurium / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D015278:Intensive Care Units, Pediatric; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage* / Q000009:adverse effects; D012107:Research Design
D009466:Neuromuscular Blocking Agents; D001279:Atracurium; C101584:cisatracurium